Bottle of pills © iStockphotos
Share tips

Five funds to buy into biotech's healthy future

The biotech sector has struggled over the past year, but it remains a solid long-term investment. Here are five good ways to buy in.
26 Nov 2019
Scientist working in a laboratory © iStockphotos
Share tips

The best way to play the biotech boom

Syncona is an unusual investment trust that invests in promising privately held biotech companies. It should be a core holding in any portfolio, says …
30 Jul 2019
DNA filled liquid being injected into an egg cell nucleus © iStockphotos
Share tips

How stem cells are changing the face of medicine

We have only just started getting to grips with the vast life-saving potential of stem cells, the basic building blocks of the body. Dr Mike Tubbs exp…
26 Jul 2019
Share tips

How to profit from the age of bespoke medicine

Doctors have traditionally approached diseases with a one-size-fits-all model. But advances in genetics and artificial intelligence are making medical…
11 Jul 2019

The drugs don’t work: stopping the spread of the superbugs

Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical co…
11 Apr 2019
Share tips

Immunotherapy: new hope in the battle against cancer

Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors …
4 Apr 2019
Stock markets

Invest in helium, biotech, and UK small caps in 2019

We asked our contributors to choose their favourite investment ideas from around the world for this year and beyond. Here’s what they came up with.
27 Dec 2018

Investing in healthcare innovation

The Worldwide Healthcare Trust provides investors with access to exciting opportunities, says Max King.
19 Oct 2018

Subscribe to MoneyWeek

Become a smarter, better informed investor with MoneyWeek.
Share tips

Where to find the pick of the bunch in biotech stocks

Professional investor Ailsa Craig picks three biotech stocks generating revenues and profits, and which have long-term patent protection.
5 Oct 2018
Share tips

A memorable day for Biogen investors

Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.
7 Sep 2018
Share tips

Three biotech stocks to buy now

Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.
27 Jul 2018
Alternative finance

Become a DIY biotech venture capitalist

A new equity crowdfunding platform wants to become the go-to place for investors in early-stage life science companies.
18 May 2018

The pharmas making pills tailored to your genes

Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the co…
19 Apr 2018
Share tips

How to invest in the next big medical breakthrough

There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company …
7 Dec 2017
Share tips

The fountain of youth will spout money for investors

Life expectancy has doubled in just a few generations, and the trend will continue,  Jim Mellon tells Merryn Somerset Webb. That’s an opportunity for …
20 Oct 2017
Share tips

How to invest in the fight against cancer

A new generation of anti-cancer drugs looks promising. There are four main ways to invest, with varying levels of risk. Dr Michael Tubbs explains.
29 Sep 2017
Share tips

Buy into this exceptional healthcare trust

Investors have an opportunity to buy into an exceptional trust in an undervalued growth sector. They should take it, says Max King.
29 Sep 2017

How to profit as Britain piles on the pounds

The world is getting fatter – and with no easy solution to obesity in sight, investing in healthcare providers and food and drink makers could bring b…
28 Sep 2017

Invest in cutting-edge healthcare

Max King looks at one fund allowing investors to put their money in cutting-edge medical research.
24 Mar 2017

The pharma price-gouging scandal

Pharmaceutical companies have hit the headlines for hiking prices for life-saving drugs by shocking amounts. What’s going on? Simon Wilson reports.
25 Dec 2016

Three promising sectors for 2017

Max King tips a host of funds in various sectors to do well in the forthcoming year.
9 Dec 2016
Share tips

Lilly fails Alzheimer’s test

Eli Lilly’s new treatment has proved ineffective in late-stage trials – yet another blow for a struggling sector, says Ben Judge.
2 Dec 2016

Who will prosper under Trump?

Now that the markets have got over the shock of a Trump victory in the US presidential election, David C Stevenson looks at which funds to buy.
25 Nov 2016

Earn a 3.5% yield from healthcare

David C Stevenson looks at the best healthcare and biotech investment trusts to tuck away in your portfolio.
11 Nov 2016
Stock markets

Novo Nordisk: Pharma giant takes a tumble

Novo Nordisk shocked investors by slashing its growth forecasts. The new CEO faces a tough start, says Ben Judge.
4 Nov 2016
Share tips

How we can profit from winning the battle against ageing

We’re now living longer than ever – only to suffer from diseases of old age. New therapies promise a new lease of life for the elderly – and big profi…
22 Sep 2016
Emerging markets

Three long-term investment ideas for the brave

Professional investor Rebecca O'Keeffe looks at three long-term investment ideas – biotech, Indian equities, and smaller companies – and picks the bes…
18 Dec 2015
Share tips

Four promising biotech stocks to buy now

The recent correction in biotech stocks was overdone, says professional investor Dr Daniel Koller. Here, he picks four biotech companies to buy now.
27 Nov 2015
Stock markets

Pfizer-Allergan megadeal combines Botox and Viagra

US drug giant Pfizer is to buy Ireland-based Allergan for $168bn, setting a new record for a merger in the pharmaceuticals industry.
26 Nov 2015

Gene editing: a cut-and-paste cure for cancer

Recent advances in the field of gene editing open up a multitude of exciting medical possibilities, says Simon Wilson. But the moral implications shou…
14 Nov 2015

Invest in the future: five game-changing technologies

Over the past 15 years, technology has revolutionised industries across the globe. Matthew Partridge looks at what will shape the next 15.
5 Nov 2015
Biotech stocks

Chart of the week: biotech spawns a monster

Valuations in the Nasdaq Biotechnology index have soared in recent years. But have we already seen the top?
16 Oct 2015
Share tips

Two biotech stocks to buy in the arms race against bugs

With antibiotic resistance costing the US healthcare system $20bn a year, there's profit in battling bugs. Matthew Partridge looks at the problem and …
4 Sep 2015

The biggest threat to modern medicine could be a big opportunity too

A crisis is looming which threatens to undermine the basis of modern medicine. As Matthew Partridge explains, that creates opportunities for drugs com…
21 Aug 2015
Stock markets

A bubble in the biotech sector?

Growth-starved investors have piled into the Nasdaq in recent years, swelling the exchange's biotech index.
14 Aug 2015
Stocks and shares

Shire’s $30bn move on Baxalta

Pharma giant Shire has made an unsolicited $30bn all-share offer for America’s Baxalta.
6 Aug 2015
Share tips

Three biotech merger targets to buy now

Professional investor Ailsa Craig picks three biotech stocks that are ripe for takeover.
10 Jul 2015
Stock markets

Chart of the week: The biotech bubble

The Nasdaq Biotechnology index has risen almost sixfold in the past ten year. In the past five, it has quadrupled.
3 Apr 2015
Share tips

Three of the best biotech stocks to buy now

Biotechnology firms are benefiting from demand from ageing populations. But as Dr Daniel Koller explains, there’s more to the biotech boom than that.
6 Mar 2015
Share tips

Three biotech stocks to buy as the sector comes of age

Investment manager Carl Harald Janson tips three biotech stocks to profit from the full range of opportunities this exciting sector has to offer.
16 Jan 2015

An exciting future for tech stocks

We live in a golden age of unprecedented technological change. Smart investors should get in early, says Jim Mellon.
30 Oct 2014

Invest for a high-tech future

Technological change is everywhere, says Merryn Somerset Webb. Investors who don't want to be left behind should read Jim Mellon's new book.
30 Oct 2014
Share tips

How Maurice Saatchi is boosting the biotech industry

Biotech companies will soon be able to get new drugs to patients much faster. That's good news for patients and investors, says Matthew Partridge.
27 Oct 2014
Share tips

This company could have made a breakthrough in cancer treatment

The best way to improve cancer treatment is early diagnosis. And this small-cap biotech company may have the key to doing just that, says Matthew Part…
23 Sep 2014
Share tips

A revolutionary new cancer treatment – and the blue-chip stock set to benefit

A new kind of cancer therapy could make a big difference to survival rates - and transform the fortunes of one big UK drugs company. Matthew Partridge…
1 Aug 2014

How to invest in the battle against ageing

As life expectancy increases, pharmas and biotechs pioneering treatments for the diseases of old age will profit handsomely, says Matthew Partridge.
17 Jul 2014
Share tips

How you could profit in the hunt for new antibiotics

The number of antibiotic-resistant bacteria is rising fast. But the search is on to find new drugs to combat them. Matthew Partridge explains how you …
3 Jul 2014
Stock markets

Drug company deals give markets a shot in the arm

A spate of merger deals between Big Pharma stocks has given the flagging sector a much-needed boost.
24 Apr 2014
Stock markets

Drug companies' 'tax inversion' dodge could backfire

Drugs companies relocating their headquarters via 'tax inversion' is a neat tax trick. But it could end up hitting their shares.
24 Apr 2014